[PDF][PDF] Solubilizing mutations used to crystallize one CFTR domain attenuate the trafficking and channel defects caused by the major cystic fibrosis mutation

LS Pissarra, CM Farinha, Z Xu, A Schmidt… - Chemistry & biology, 2008 - cell.com
LS Pissarra, CM Farinha, Z Xu, A Schmidt, PH Thibodeau, Z Cai, PJ Thomas, DN Sheppard…
Chemistry & biology, 2008cell.com
Cystic fibrosis (CF) is caused by mutations in the CF transmembrane conductance regulator
(CFTR) Cl− channel. F508del, the most frequent CF-causing mutation, disrupts both the
processing and function of CFTR. Recently, the crystal structure of the first nucleotide-
binding domain of CFTR bearing F508del (F508del-NBD1) was elucidated. Although
F508del-NBD1 shows only minor conformational changes relative to that of wild-type NBD1,
additional mutations (F494N/Q637R or F429S/F494N/Q637R) were required for domain …
Summary
Cystic fibrosis (CF) is caused by mutations in the CF transmembrane conductance regulator (CFTR) Cl channel. F508del, the most frequent CF-causing mutation, disrupts both the processing and function of CFTR. Recently, the crystal structure of the first nucleotide-binding domain of CFTR bearing F508del (F508del-NBD1) was elucidated. Although F508del-NBD1 shows only minor conformational changes relative to that of wild-type NBD1, additional mutations (F494N/Q637R or F429S/F494N/Q637R) were required for domain solubility and crystallization. Here we show that these solubilizing mutations in cis with F508del partially rescue the trafficking defect of full-length F508del-CFTR and attenuate its gating defect. We interpret these data to suggest that the solubilizing mutations utilized to facilitate F508del-NBD1 production also assist folding of full-length F508del-CFTR protein. Thus, the available crystal structure of F508del-NBD1 might correspond to a partially corrected conformation of this domain.
cell.com